Private Capital Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$135K Buy
3,634
+368
+11% +$15K 0.1% 199
2022
Q1
$145K Buy
3,266
+82
+3% +$3.55K 0.03% 298
2021
Q4
$135K Buy
3,184
+248
+8% +$10.4K 0.03% 329
2021
Q3
$127K Buy
2,936
+963
+49% +$42.6K 0.03% 339
2021
Q2
$84K Buy
1,973
+40
+2% +$1.68K 0.02% 476
2021
Q1
$75K Sell
1,933
-770
-28% -$29.1K 0.02% 484
2020
Q4
$97K Buy
2,703
+544
+25% +$19.6K 0.02% 510
2020
Q3
$82K Buy
2,159
+684
+46% +$26.4K 0.02% 511
2020
Q2
$52K Buy
1,475
+283
+24% +$10.2K 0.01% 687
2020
Q1
$39K Sell
1,192
-716
-38% -$28K 0.01% 746
2019
Q4
$86K Buy
1,908
+1,351
+243% +$56.5K 0.02% 492
2019
Q3
$23K Buy
557
+30
+6% +$1.27K ﹤0.01% 1121
2019
Q2
$17K Buy
527
+64
+14% +$2.46K ﹤0.01% 1149
2019
Q1
$18K Sell
463
-846
-65% -$32.3K ﹤0.01% 1251
2018
Q4
$46K Buy
1,309
+937
+252% +$34K 0.01% 701
2018
Q3
$14K Sell
372
-155
-29% -$5.41K ﹤0.01% 1301
2018
Q2
$17K Hold
527
﹤0.01% 1181
2018
Q1
$14K Sell
527
-31
-6% -$843 ﹤0.01% 1219
2017
Q4
$14 Buy
+558
New +$15.4K ﹤0.01% 1219

Other funds holding BSX

Private Capital Group's BSX Position: Q2 2022 in Review

Private Capital Group increased its Boston Scientific (BSX) stake by 11% in Q2 2022, buying an estimated $15K and bringing the position to 3,634 shares worth $135K. The position accounts for 0.1% of the portfolio, ranked #199.

Private Capital Group first reported a position in BSX in Q4 2017 and has held it in 19 quarters since. The position peaked at $145K in Q1 2022. 879 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

  • Private Capital Group held 3,634 shares of Boston Scientific worth $135K as of Q2 2022.
  • Private Capital Group bought 368 Boston Scientific shares in Q2 2022, an estimated $15K.
  • Boston Scientific made up 0.1% of Private Capital Group's portfolio in Q2 2022, its #199 holding.
  • Private Capital Group first reported a position in Boston Scientific in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's Boston Scientific position peaked at $145K in Q1 2022.
  • 879 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.